In AOM/DSS-induced CRC mice, we found that the reduction in MDSCs and concomitant increase in CD8+ T cells in the tumor, blood and/or spleen correlated with the preventive effects of C5 and C5ar1 deficiency, and a C5aR1 antagonist on CRC development. Here, CD8A is linked to neoplasm.